Commercial Update-Expansion of ColoSTAT ordering capability
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Rhythm Biosciences Limited announced that its ColoSTAT® test can now be ordered through popular GP software used by most Australian practices, enhancing accessibility for patients. Rhythm aims to drive adoption of the test among GPs through marketing and direct engagement, focusing on integrating it into routine clinical workflows.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- RHY Q1 FY27 Update
- Quarterly Activities Report and Appendix 4C
- Notice of Annual General Meeting/Proxy Form
- ColoSTAT Economic Study - Australian Public Health Savings
- Final Director's Interest Notice - Gavin Fox-Smith
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences